345. Tanaka M. Dendrite formation of cerebellar Purkinje cells. Neurochem Res. 2009;34:2078-88.

346. Boukhtouche F, Janmaat S, Vodjdani G, Gautheron V, Mallet J, Dusart I, et al. Retinoid-related orphan receptor alpha controls the early steps of Purkinje cell dendritic differentiation. J Neurosci. 2006;26:1531-8.

347. Kapfhammer JP. Cellular and molecular control of dendritic growth and development of cerebellar Purkinje cells. Prog Histochem Cytochem. 2004;39:131-82.

348. Rossi F, Tempia F. Unravelling the Purkinje neuron. Cerebellum. 2006;5:75-6.

349. y Cajal RS. Sur les fibres moussues et quelques points douteux de la texture de l'écorce cérébelleuse. Trab Lab Invest Biol Univ Madrid. 1926;24:215-51.

350. Armengol JA, Sotelo C. Early dendritic development of Purkinje cells in the rat cerebellum. A light and electron microscopic study using axonal tracing in 'in vitro' slices. Brain Res Dev Brain Res. 1991;64:95-114.

351. Berry M, Bradley P. The growth of the dendritic trees of Purkinje cells in the cerebellum of the rat. Brain Res. 1976;112:1-35.

352. Kaneko M, Yamaguchi K, Eiraku M, Sato M, Takata N, Kiyohara Y, et al. Remodeling of monoplanar Purkinje cell dendrites during cerebellar circuit formation. PLoS ONE. 2011;6:e20108.

353. van Welie I, Smith IT, Watt AJ. The metamorphosis of the developing cerebellar micro-circuit. Curr Opin Neurobiol. 2011;21:245-53.

354. Dusart I, Flamant F. Profound morphological and functional changes of rodent Purkinje cells between the first and the second postnatal weeks: a metamorphosis? Front Neuroanat. 2012;6:11.

355. Avci HX, Lebrun C, Wehrle R, Doulazmi M, Chatonnet F, Morel M-P, et al. Thyroid hormone triggers the developmental loss of axonal regenerative capacity via thyroid hormone receptor α1 and kruppel-like factor 9 in Purkinje cells. Proc Natl Acad Sci U S A. 2012;109:14206-11.

356. Sotelo C, Dusart I. Intrinsic versus extrinsic determinants during the development of Purkinje cell dendrites. Neuroscience. 2009;162:589-600.

357. Tanaka M. The dendritic differentiation of Purkinje neurons: Unsolved mystery in formation of unique dendrites. Cerebellum. 2014.

358. Chen XR, Heck N, Lohof AM, Rochefort C, Morel MP, Wehrle R, et al. Mature Purkinje cells require the retinoic acid-related orphan receptor-α (RORα) to maintain climbing fiber mono-innervation and other adult characteristics. J Neurosci. 2013;33:9546-62.

359. Lefebvre JL, Kostadinov D, Chen WV, Maniatis T, Sanes JR. Protocadherins mediate dendritic self-avoidance in the mammalian nervous system. Nature. 2013;488:517-21.

360. Gibson DA, Tymanskyj S, Yuan RC, Leung HC, Lefebvre JL, Sanes JR, et al. Dendrite self-avoidance requires cell-autonomous Slit/Robo signaling in Purkinje cells. Neuron. 2014;81:1040-56.

361. Joo W, Hippenmeyer S, Luo L. Dendrite morphogenesis depends on relative levels of NT3/TrkC signaling. Science. 2014;346:626-9.

362. Bolduc ME, Limperopoulos C. Neurodevelopmental outcomes in children with cerebellar malformations: a systematic review. Dev Med Child Neurol. 2009;51:256-67.

363. Tavano A, Grasso R, Gagliardi C, Triulzi F, Bresolin N, Fabbro F, et al. Disorders of cognitive and affective development in cerebellar malformations. Brain. 2007;130:2646-60.

364. Volpe JJ. Cerebellum of the premature infant: rapidly developing, vulnerable, clinically important. J Child Neurol. 2009;24:1085-104.

365. Barkovich AJ, Millen KJ, Dobyns WB. A developmental and genetic classification for midbrain-hindbrain malformations. Brain. 2009;132:3199-230.

366. Parisi MA, Dobyns WB. Human malformations of the midbrain and hindbrain: review and proposed classification scheme. Mol Genet Metab. 2003;80:36-53.

367. Osenbach RK, Menezes AH. Diagnosis and management of the Dandy-Walker malformation: 30 years of experience. Pediatr Neurosurg. 1992;18:179-89.

368. Sato K, Kubota T, Nakamura Y. Adult onset of the Dandy-Walker syndrome. Br J Neurosurg. 1996;10:109-12.

369. Tal Y, Freigang B, Dunn HG, Durity FA, Moyes PD. Dandy-Walker syndrome: analysis of 21 cases. Dev Med Child Neurol. 1980;22:189-201.

370. Aldinger KA, Lehmann OJ, Hudgins L, Chizhikov VV, Bassuk AG, Ades LC, et al. FOXC1 is required for normal cerebellar development and is a major contributor to chromosome 6p25.3 Dandy-Walker malformation. Nat Genet. 2009;41:1037-42.

371. Grinberg I, Northrup H, Ardinger H, Prasad C, Dobyns WB, Millen KJ. Heterozygous deletion of the linked genes ZIC1 and ZIC4 is involved in Dandy-Walker malformation. Nat Genet. 2004;36:1053-5.

372. Limperopoulos C, Folkterth R, Barnewolt CE, Connolly S, Du Plessis AJ. Posthemorrhagic cerebellar disruption mimicking Dandy-Walker malformation: fetal imaging and neuropathology findings. Semin Pediatr Neurol. 2010;17:75-81.

373. Haldipur P, Gillies GS, Janson OK, Chizhikov VV, Mithal DS, Miller RJ, et al. Foxc1 dependent mesenchymal signalling drives embryonic cerebellar growth. E-life. 2014;3.

374. Kroes HY, van Zon PH, van de Putte DF, Nelen MR, Nievelstein RJ, Wittebol-Post D, et al. DNA analysis of AHI1, NPHP1 and CYCLIN D1 in Joubert syndrome patients from the Netherlands. Eur J Med Genet. 2008;51:24-34.

375. Parisi MA, Doherty D, Chance PF, Glass IA. Joubert syndrome (and related disorders) (OMIM 213300). Eur J Hum Genet. 2007;15:511-21.

376. Maria BL, Quisling RG, Rosainz LC, Yachnis AT, Gitten J, Dede D, et al. Molar tooth sign in Joubert syndrome: clinical, radiologic, and pathologic significance. J Child Neurol. 1999;14:368-76.

377. Romani M, Micalizzi A, Kraoua I, Dotti MT, Cavallin M, Sztriba L, et al. Mutations in B9D1 and MKS1 cause mild Joubert syndrome: expanding the genetic overlap with the lethal ciliopathy Meckel syndrome. Orphanet J Rare Dis. 2014;9:72.

378. Romani M, Micalizzi A, Valente EM. Joubert syndrome: congenital cerebellar ataxia with the molar tooth. Lancet Neurol. 2013;12:894-905.

379. Aguilar A, Meunier A, Strehl L, Martinovic J, Bonniere M, Attie-Bitach T, et al. Analysis of human samples reveals impaired SHH-dependent cerebellar development in Joubert syndrome/Meckel syndrome. Proc Natl Acad Sci U S A. 2012;109:16951-6.

380. Lancaster MA, Gopal DJ, Kim J, Saleem SN, Silhavy JL, Louie CM, et al. Defective Wnt-dependent cerebellar midline fusion in a mouse model of Joubert syndrome. Nat Med. 2011;17:726-31.

381. Schneider L, Clement CA, Teilmann SC, Prazour GJ, Hoffmann EK, Satir P, et al. PDGFRαα signaling is regulated through the primary cilium in fibroblasts. Curr Biol. 2005;15:1861-6.

382. Koster RW, Fraser SE. Direct imaging of in vivo neuronal migration in the developing cerebellum. Curr Biol. 2001;11(23):1858-63.

383. Battini R, D'Arrigo S, Cassandrini D, Guzzetta A, Fiorillo C. Pantaleoni C, et al. Novel mutations in TSEN54 in pontocerebellar hypoplasia type 2. J Child Neurol. 2014;29:520-5.

384. Bierhals T, Korenke GC, Uyanik G, Kutsche K. Pontocerebellar hypoplasia type 2 and TSEN2: review of the literature and two novel mutations. Eur J Med Genet. 2013;56:325-30.

385. Fallet-Bianco C, Laquerriere A, Poirier K, Razavi F, Guimiot F, Dias P, et al. Mutations in tubulin genes are frequent causes of various foetal malformations of cortical development including microlissencephaly. Acta Neuropathol Commun. 2014;2:69.
386. Hong SE, Shugart YY, Huang DT, Shahwan SA, Grant PE, Hourihane JO, et al. Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat Genet. 2000;26:93-6.

387. Miyata H, Chute DJ, Fink J, Villablanca P, Vinters HV. Lissencephaly with agenesis of corpus callosum and rudimentary dysplastic cerebellum: a subtype of lissencephaly with cerebellar hypoplasia. Acta Neuropathol. 2004;107:69-81.

388. Nakamura K, Nishiyama K, Kodera H, Nakashima M, Tsurusaki Y, Miyake N, et al. A de novo CASK mutation in pontocerebellar hypoplasia type 3 with early myoclonic epilepsy and tetralogy of Fallot. Brain Dev. 2014;36:272-3.

389. Rocas D, Alix E, Michel J, Cordier MP, Labalme A, Guilbert H, et al. Neuropathological features in a female fetus with OPHN1 deletion and cerebellar hypoplasia. Eur J Med Genet. 2013;56: 270-3.

390. Saitsu H, Kato M, Osaka H, Moriyama N, Horita H, Nishiyama K, et al. CASK aberrations in male patients with Ohtahara syndrome and cerebellar hypoplasia. Epilepsia. 2012;53:1441-9.

391. Tentler D, Gustavsson P, Leisti J, Schueler M, Chelly J, Timonen E, et al. Deletion including the oligophrenin-1 gene associated with enlarged cerebral ventricles, cerebellar hypoplasia, seizures and ataxia. Eur J Hum Genet. 1999;7:541-8.

392. Yu T, Meiners LC, Danielsen K, Wong MT, Bowler T, Reinberg D, et al. Deregulated FGF and homeotic gene expression underlies cerebellar vermis hypoplasia in CHARGE syndrome. E-life. 2013;2:e01305.

393. Barkovich AJ, Lindan CE. Congenital cytomegalovirus infection of the brain: imaging analysis and embryologic considerations. AJNR Am J Neuroradiol. 1994;15:703-15.

394. Bellini C, Massocco D, Serra G. Prenatal cocaine exposure and the expanding spectrum of brain malformations. Arch Intern Med. 2000;160:2393.

395. Bookstein FL, Streissguth AP, Connor PD, Sampson PD. Damage to the human cerebellum from prenatal alcohol exposure: the anatomy of a simple biometrical explanation. Anat Rec B New Anat. 2006;289:195-209.

396. de Vries LS, Gunardi H, Barth PG, Bok LA, Verboon-Maciolek MA, Groenendaal F. The spectrum of cranial ultrasound and magnetic resonance imaging abnormalities in congenital cytomegalovirus infection. Neuropediatrics. 2004;35:113-9.

397. Norman AL, Crocker N, Mattson SN, Riley EP. Neuroimaging and fetal alcohol spectrum disorders. Dev Disabil Res Rev. 2009;15:209-17.

398. Velioglu SK, Kuzeyli K, Zzmenoglu M. Cerebellar agenesis: a case report with clinical and MR imaging findings and a review of the literature. Eur J Neurol. 1998;5:503-6.

399. Timmann D, Dimitrova A, Hein-Kropp C, Wilhelm H, Dorfler A. Cerebellar agenesis: clinical, neuropsychological and MR findings. Neurocase. 2003;9:402-13.

400. Sellick GS, Barker KT, Stolte-Dijkstra I, Fleischmann C, Coleman RJ, Garrett C, et al. Mutations in PTF1A cause pancreatic and cerebellar agenesis. Nat Genet. 2004;36:1301-5.

401. Hayashi M, Poretti A, Gorra M, Farzin A, Graham EM, Huisman TA, et al. Prenatal cerebellar hemorrhage: fetal and postnatal neuroimaging findings and postnatal outcome. Pediatr Neurol. 2015;52(5):529-34.

402. Koibuchi N, Chin WW. Thyroid hormone action and brain development. Trends Endocrinol Metab. 2000;11:123-8.

403. Koibuchi N, Jingu H, Iwasaki T, Chin WW. Current perspectives on the role of thyroid hormone in growth and development of cerebellum. Cerebellum. 2003;2:279-89.

404. Porterfield SP, Hendrich CE. The role of thyroid hormones in prenatal and neonatal neurological development-current perspectives. Endocr Rev. 1993;14:94-106.

405. Calvo R, Obregon MJ, de Ruiz Ona C, del Escobar Rey F, de Morreale Escobar G. Congenital hypothyroidism, as studied in rats. J Clin Invest. 1990;86:889-99.

406. Guadano-Ferraz A, Obregon MJ, St Germain DL, Bernal J. The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain. Proc Natl Acad Sci U S A. 1997;94:10391-6.

407. Heuer H, Maier MK, Iden S, Mittag J, Friesema ECH, Visser TJ, et al. The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology. 2005;146:1701-6.

408. Lazar MA. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev. 1993;14:184-93.

409. Lauder JM, Altman J, Krebs H. Some mechanisms of cerebellar foliation: effects of early hypo- and hyperthyroidism. Brain Res. 1974;76:33-40.

410. Bradley DJ, Towle HC, Young III WS. Spatial and temporal expression of alpha- and beta-thyroid hormone receptor mRNAs, including the beta 2-subtype, in the developing mammalian nervous system. J Neurosci. 1992;12:2288-302.

411. Koibuchi N, Yamaoka S, Chin WW. Effect of altered thyroid status on neurotrophin gene expression during postnatal development of the mouse cerebellum. Thyroid. 2001;11:205-10.

412. Strait KA, Zou L, Oppenheimer JH. β1 isoform-specific regulation of a triiodothyronine-induced gene during cerebellar development. Mol Endocrinol. 1992;6:1874-80.

413. Oppenheimer JH, Schwartz HL. Molecular basis of thyroid hormone-dependent brain development. Endocr Rev. 1997;18: 462-75.

414. Koibuchi N. Animal models to study thyroid hormone action in cerebellum. Cerebellum. 2009;8:89-97.

415. Portella AC, Carvalho F, Faustino L, Wondisford FE, Ortiga-Carvalho TM, Gomes FC. Thyroid hormone receptor β mutation causes severe impairment of cerebellar development. Mol Cell Neurosci. 2010;44:68-77.

416. Venero C, Guadaño-Ferraz A, Herrero AI, Nordström K, Manzano J, de Escobar GM, et al. Anxiety, memory impairment, and locomotor dysfunction caused by a mutant thyroid hormone receptor α1 can be ameliorated by T3 treatment. Genes Dev. 2005;19: 2152-63.

417. Fauquier T, Chatonnet F, Picou F, Richard S, Fossat N, Aguilera N, et al. Purkinje cells and Bergmann glia are primary targets of the TRα1 thyroid hormone receptor during mouse cerebellum postnatal development. Development. 2014;141:166-75.

418. Yu L, Iwasaki T, Xu M, Lesmana R, Xiong Y, Shimokawa N, et al. Aberrant cerebellar development of transgenic mice expressing dominant-negative thyroid hormone receptor in cerebellar Purkinje cells. Endocrinology. 2015;156(4):1565-76.

419. Ibhazehiebo K, Koibuchi N. Impact of endocrine disrupting chemicals on thyroid function and brain development. Expert Rev Endocrinol Metab. 2014;9:579-91.

420. Klockgether T, Paulson H. Milestones in ataxia. Mov Disord. 2011;26:1134-41.

421. Manto M, Marmolino D. Cerebellar ataxias. Curr Opin Neurol. 2009;22:419-29.

422. Hersheson J, Haworth A, Houlden H. The inherited ataxias: genetic heterogeneity, mutation databases, and future directions in research and clinical diagnostics. Hum Mutat. 2012;33:1324-32.

423. Mancuso M, Orsucci D, Siciliano G, Bonuccelli U. The genetics of ataxia: through the labyrinth of the Minotaur, looking for Ariadne's thread. J Neurol. 2014;261:528-41.

424. Orr HT. SCA1-phosphorylation, a regulator of Ataxin-1 function and pathogenesis. Prog Neurobiol. 2012;99:179-85.

425. Serra HG, Duvick L, Zu T, Carlson K, Stevens S, Jorgensen N, et al. RORα-mediated Purkinje cell development determines disease severity in adult SCA1 mice. Cell. 2006;127:697-708.
426. Ebner BA, Ingram MA, Barnes JA, Duvick LA, Frisch JL, Clark HB, et al. Purkinje cell ataxin-1 modulates climbing fiber synaptic input in developing and adult mouse cerebellum. *J Neurosci.* 2013;33:5806–20.

427. Duvick L, Barnes J, Ebner B, Agrawal S, Andresen M, Lim J, et al. SCA1-like disease in mice expressing wild-type ataxin-1 with a serine to aspartic acid replacement at residue 776. *Neuron.* 2010;67:929–35.

428. Gold DA, Gent PM, Hamilton BA. RORα in genetic control of cerebellum development: 50 staggering years. *Brain Res.* 2007;1140:19–25.

429. Mitsumura K, Hosoi N, Furuya N, Hirai H. Disruption of metabotropic glutamate receptor signalling is a major defect at cerebellar parallel fibre-Purkinje cell synapses in staggerer mutant mice. *J Physiol.* 2011;589:3191–209.

430. Torashima T, Koyama C, Iizuka A, Mitsumura K, Takayama K, Yanagi S, et al. Lentivector-mediated rescue from cerebellar ataxia in a mouse model of spinocerebellar ataxia. *EMBO Rep.* 2008;9:393–9.

431. Konno A, Miyake N, Miyake K, Matsuura S, Huda F, Nakamura K, et al. Mutant Ataxin-3 with an abnormally expanded polyglutamine chain disrupts dendritic development and metabotropic glutamate receptor signaling in mouse cerebellar Purkinje cells. *Cerebellum.* 2013;13:29–41.

432. Gao Y, Perkins EM, Clarkson YL, Tobia S, Lyndon AR, Jackson M, et al. β-III spectrin is critical for development of Purkinje cell dendritic tree and spine morphogenesis. *J Neurosci.* 2011;31:16581–90.

433. Seki T, Shimahara T, Yamamoto K, Abe N, Amano T, Adachi N, et al. Mutant γPKC found in spinocerebellar ataxia type 14 induces aggregate-independent maldevelopment of dendrites in primary cultured Purkinje cells. *Neurobiol Dis.* 2009;33:260–73.

434. Shuvaev AN, Horiuchi H, Seki T, Goenawan H, Irie T, Iizuka A, et al. Mutant PKCγ in spinocerebellar ataxia type 14 disrupts synapse elimination and long-term depression in Purkinje cells in vivo. *J Neurosci.* 2011;31:14324–34.

435. Ji J, Hassler ML, Shimobayashi E, Paka N, Streit R, Kapfhammer JP. Increased protein kinase Cγ activity induces Purkinje cell pathology in a mouse model of spinocerebellar ataxia 14. *Neurobiol Dis.* 2014;70:1–11.

436. Becker EBE, Oliver PL, Glitsch MD, Banks GT, Achilli F, Hardy A, et al. A point mutation in TRPC3 causes abnormal Purkinje cell development and cerebellar ataxia in moonwalker mice. *Proc Natl Acad Sci U S A.* 2009;106:6706–11.

437. Becker EBE. The Moonwalker mouse: new insights into TRPC3 function, cerebellar development, and ataxia. *Cerebellum.* 2014;13:628–36.

438. Hartmann J, Dragicevic E, Adelsberger H, Henning HA, Sumser M, Abramowitz J, et al. TRPC3 channels are required for synaptic transmission and motor coordination. *Neuron.* 2008;59:392–8.

439. Mitsumura K, Hosoi N, Furuya N, Hirai H. Disruption of metabotropic glutamate receptor signalling is a major defect at cerebellar parallel fibre-Purkinje cell synapses in staggerer mutant mice. *J Physiol.* 2011;589(Pt 13):3191–209.

440. Skinner PJ, Vierra-Green CA, Clark HB, Zoghbi HY, Orr HT. Altered trafficking of membrane proteins in Purkinje cells of SCA1 transgenic mice. *Am J Pathol.* 2001;159:905–13.

441. Konno A, Shuvaev AN, Miyake N, Miyake K, Iizuka A, Matsuura S, et al. Mutant ataxin-3 with an abnormally expanded polyglutamine chain disrupts dendritic development and metabotropic glutamate receptor signaling in mouse cerebellar Purkinje cells. *Cerebellum.* 2014;13(1):29–41.

442. Armbrust KR, Wang X, Hathorn TJ, Cramer SW, Chen G, Zu T, et al. Mutant β-III spectrin causes mGluR1α mislocalization and functional deficits in a mouse model of spinocerebellar ataxia type 5. *J Neurosci.* 2014;34:9891–904.

443. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. *Acta Neuropathol.* 2007;114:97–109.

444. Kool M, Korshunov A, Remke M, Jones DT, Schlanstein M, Northcott PA, et al. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. *Acta Neuropathol.* 2012;123:473–84.

445. Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC, et al. Molecular subgroups of medulloblastoma: the current consensus. *Acta Neuropathol.* 2012;123:465–72.

446. Yang ZJ, Ellis T, Markant SL, Read TA, Kessler JD, Bourboulas M, et al. Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. *Cancer Cell.* 2008;14:135–45.

447. Oliver TG, Read TA, Kessler JD, Mehmeti A, Wells JF, Huynh TT, et al. Loss of patched and disruption of granule cell development in a pre-neoplastic stage of medulloblastoma. *Development.* 2005;132:2425–39.

448. Grammel D, Warmuth-Metz M, von Bueren AO, Kool M, Pietsch T, Kretzschmar HA, et al. Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem. *Acta Neuropathol.* 2012;123:601–14.

449. Gibson P, Tong Y, Robinson G, Thompson MC, Currle DS, Eden C, et al. Subtypes of medulloblastoma have distinct developmental origins. *Nature.* 2010;468:1095–9.

450. Perreault S, Ramaswamy V, Achrol AS, Chao K, Liu TT, Shih D, et al. MRI surrogates for molecular subgroups of medulloblastoma. *AJNR Am J Neuroradiol.* 2014;35:1263–9.

451. Wefers AK, Warmuth-Metz M, Poschl J, von Bueren AO, Monoranu CM, Seelos K, et al. Subgroup-specific localization of human medulloblastoma based on pre-operative MRI. *Acta Neuropathol.* 2014;127:931–3.

452. Ellison DW, Dalton J, Kocak M, Nicholson SL, Fraga C, Neale G, et al. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. *Acta Neuropathol.* 2011;121:381–96.

453. Shakhova O, Leung C, van Montfort E, Berns A, Marino S. Lack of Rb and p53 delays cerebellar development and predisposes to large cell anaplastic medulloblastoma through amplification of N-Myc and Ptch2. *Cancer Res.* 2006;66:5190–200.

454. Sutter R, Shakhova O, Bhagat H, Behesti H, Sutter C, Penkar S, et al. Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas. *Oncogene.* 2010;29:1845–56.

455. Pei Y, Moore CE, Wang J, Tewari AK, Eroshkin A, Cho YJ, et al. An animal model of MYC-driven medulloblastoma. *Cancer Cell.* 2012;21:155–67.

456. Elsen G, Juric-Sejkhar G, Daza R, Hevner RF. Development of cerebellar nuclei. In: Manto M, Gruol D, Schmahmann J, Koibuchi N, Rossi F, editors. *Handbook of cerebellum and cerebellum disorders. Heidelberg: Springer.* 2010.

457. Kim E, Wang Y, Kim SJ, Bornhorst M, Jecrois ES, Anthony TE, et al. Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1. *E-life.* 2014;3.

458. Meier F, Giesert F, Delic S, Faus-Kessler T, Matheus F, Simeone A, et al. FGF/FGFR2 signaling regulates the generation and correct positioning of Bergmann glia cells in the developing mouse cerebellum. *PLoS One.* 2014;9:e101124.

459. Sathyamurthy A, Yin DM, Barik A, Shen C, Bean JC, Figueiredo D, et al. ERBB3-mediated regulation of Bergmann glia proliferation in cerebellar lamination. *Development.* 2015;142:522–32.